Abdominal distension
2 papers
- Human trial1
Latest
ADA Scientific Sessions 2025 Abstract
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 Tablet, an Oral Dual GLP-1/GIP Receptor Agonist, in Healthy Participants—A Phase 1 Study
Randomised trial in peopleInterventions
ADA Scientific Sessions 2025 Abstract
Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP-1/GIP Receptor Agonist (HDM1005)—A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose-Escalation Study
Randomised trial in 64 peopleInterventions